Athos Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Athos Capital’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-273,000	Closed	-$4.29M	–	143
2022 Q2	$4.29M	Buy	+273,000	New	+$4.17M	1.62%	12

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Athos Capital's NPTN Position: Q3 2022 in Review

Athos Capital sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 273,000 shares — an estimated $4.29M sold.

Athos Capital first reported a position in NPTN in Q2 2022 and held it in 1 quarter. The position peaked at $4.29M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Athos Capital reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Athos Capital sold 273,000 NEOPHOTONICS CORP shares in Q3 2022, an estimated $4.29M.
Athos Capital first reported a position in NEOPHOTONICS CORP in Q2 2022 and held it in 1 quarter.
Athos Capital's NEOPHOTONICS CORP position peaked at $4.29M in Q2 2022.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Athos Capital's 13F filing for Q3 2022, filed 14 Nov 2022.